Aligos Therapeutics Stock Price History
ALGS Stock | USD 22.99 1.64 7.68% |
If you're considering investing in Aligos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aligos Therapeutics stands at 22.99, as last reported on the 28th of November, with the highest price reaching 23.70 and the lowest price hitting 21.51 during the day. Aligos Therapeutics is risky given 3 months investment horizon. Aligos Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.58% are justified by taking the suggested risk. Use Aligos Therapeutics Mean Deviation of 6.53, risk adjusted performance of 0.1058, and Downside Deviation of 9.14 to evaluate company specific risk that cannot be diversified away.
At this time, Aligos Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 33.9 M in 2024, whereas Common Stock is likely to drop 4,767 in 2024. . At this time, Aligos Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 4.71 in 2024, whereas Price Earnings Ratio is likely to drop (4.94) in 2024. Aligos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aligos |
Sharpe Ratio = 0.1332
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ALGS | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
11.85 actual daily | 96 96% of assets are less volatile |
Expected Return
1.58 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Aligos Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aligos Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.5291 | Enterprise Value Ebitda 0.5749 | Price Sales 13.7545 | Shares Float 419.9 K | Wall Street Target Price 103.3333 |
Aligos Therapeutics Stock Price History Chart
There are several ways to analyze Aligos Stock price data. The simplest method is using a basic Aligos candlestick price chart, which shows Aligos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 27, 2024 | 22.99 |
Lowest Price | October 10, 2024 | 6.89 |
Aligos Therapeutics November 28, 2024 Stock Price Synopsis
Various analyses of Aligos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aligos Stock. It can be used to describe the percentage change in the price of Aligos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aligos Stock.Aligos Therapeutics Price Daily Balance Of Power | 0.75 | |
Aligos Therapeutics Price Action Indicator | 1.20 | |
Aligos Therapeutics Price Rate Of Daily Change | 1.08 |
Aligos Therapeutics November 28, 2024 Stock Price Analysis
Aligos Stock Price History Data
The price series of Aligos Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 16.1 with a coefficient of variation of 38.67. The prices are distributed with arithmetic mean of 11.84. The median price for the last 90 days is 9.83. The company had 1:25 stock split on 19th of August 2024.Open | High | Low | Close | Volume | ||
11/28/2024 | 22.61 | 23.70 | 21.51 | 22.99 | ||
11/27/2024 | 22.61 | 23.70 | 21.51 | 22.99 | 278,654 | |
11/26/2024 | 20.48 | 22.46 | 19.50 | 21.35 | 371,657 | |
11/25/2024 | 20.30 | 21.89 | 19.50 | 20.46 | 435,758 | |
11/22/2024 | 20.01 | 20.44 | 18.75 | 20.04 | 437,524 | |
11/21/2024 | 18.17 | 19.98 | 17.26 | 19.79 | 637,020 | |
11/20/2024 | 18.51 | 19.85 | 17.88 | 18.20 | 495,961 | |
11/19/2024 | 19.79 | 24.84 | 14.65 | 18.50 | 1,523,932 | |
11/18/2024 | 19.45 | 20.15 | 17.85 | 20.12 | 387,247 | |
11/15/2024 | 19.91 | 20.59 | 17.26 | 19.17 | 423,745 | |
11/14/2024 | 19.43 | 20.44 | 15.66 | 19.46 | 672,548 | |
11/13/2024 | 18.80 | 21.89 | 18.20 | 19.58 | 1,220,378 | |
11/12/2024 | 15.46 | 18.00 | 14.09 | 17.85 | 1,478,114 | |
11/11/2024 | 10.32 | 17.70 | 10.32 | 13.99 | 3,161,531 | |
11/08/2024 | 9.87 | 10.41 | 9.68 | 10.19 | 108,249 | |
11/07/2024 | 9.08 | 10.45 | 9.02 | 9.92 | 174,545 | |
11/06/2024 | 10.00 | 10.00 | 9.20 | 9.35 | 75,675 | |
11/05/2024 | 9.51 | 9.88 | 9.32 | 9.83 | 78,813 | |
11/04/2024 | 9.58 | 9.89 | 9.35 | 9.48 | 52,362 | |
11/01/2024 | 9.81 | 10.30 | 9.33 | 9.55 | 61,471 | |
10/31/2024 | 10.05 | 10.05 | 8.88 | 9.78 | 147,965 | |
10/30/2024 | 9.37 | 10.39 | 9.12 | 9.77 | 360,116 | |
10/29/2024 | 8.82 | 9.40 | 8.43 | 9.36 | 123,894 | |
10/28/2024 | 8.41 | 9.27 | 8.18 | 8.87 | 181,150 | |
10/25/2024 | 9.14 | 9.20 | 8.10 | 8.40 | 200,937 | |
10/24/2024 | 7.16 | 10.35 | 7.10 | 9.03 | 921,026 | |
10/23/2024 | 7.37 | 7.45 | 7.16 | 7.21 | 21,261 | |
10/22/2024 | 7.36 | 7.55 | 7.10 | 7.34 | 44,650 | |
10/21/2024 | 7.38 | 7.38 | 7.09 | 7.29 | 10,058 | |
10/18/2024 | 7.28 | 7.43 | 7.19 | 7.25 | 9,720 | |
10/17/2024 | 7.19 | 7.39 | 7.16 | 7.21 | 17,386 | |
10/16/2024 | 7.32 | 7.43 | 7.15 | 7.38 | 28,771 | |
10/15/2024 | 7.45 | 7.45 | 7.04 | 7.27 | 15,758 | |
10/14/2024 | 7.60 | 7.60 | 6.98 | 7.23 | 80,942 | |
10/11/2024 | 6.85 | 7.70 | 6.85 | 7.62 | 62,684 | |
10/10/2024 | 7.61 | 7.75 | 6.84 | 6.89 | 83,555 | |
10/09/2024 | 7.22 | 7.85 | 7.21 | 7.76 | 31,585 | |
10/08/2024 | 7.57 | 7.72 | 6.76 | 7.32 | 69,605 | |
10/07/2024 | 8.06 | 8.17 | 7.50 | 7.50 | 49,357 | |
10/04/2024 | 8.23 | 8.48 | 7.93 | 8.16 | 37,959 | |
10/03/2024 | 8.44 | 8.67 | 8.01 | 8.19 | 36,196 | |
10/02/2024 | 8.49 | 8.82 | 8.37 | 8.59 | 28,949 | |
10/01/2024 | 8.57 | 9.19 | 8.36 | 8.62 | 31,939 | |
09/30/2024 | 7.96 | 9.77 | 7.96 | 8.66 | 77,736 | |
09/27/2024 | 8.02 | 8.17 | 7.83 | 8.04 | 51,456 | |
09/26/2024 | 8.22 | 8.37 | 7.82 | 8.02 | 29,175 | |
09/25/2024 | 8.15 | 8.48 | 8.02 | 8.22 | 33,217 | |
09/24/2024 | 8.50 | 8.50 | 7.35 | 8.15 | 129,005 | |
09/23/2024 | 9.09 | 9.35 | 7.80 | 8.10 | 114,035 | |
09/20/2024 | 10.60 | 10.95 | 9.14 | 9.14 | 238,862 | |
09/19/2024 | 12.81 | 13.11 | 9.90 | 10.18 | 875,365 | |
09/18/2024 | 14.34 | 15.25 | 14.00 | 14.16 | 62,076 | |
09/17/2024 | 14.41 | 14.90 | 13.68 | 14.39 | 30,616 | |
09/16/2024 | 14.67 | 15.07 | 14.06 | 14.22 | 31,671 | |
09/13/2024 | 13.87 | 15.30 | 13.82 | 14.80 | 41,535 | |
09/12/2024 | 14.38 | 16.24 | 13.30 | 14.03 | 95,027 | |
09/11/2024 | 14.17 | 14.75 | 13.35 | 13.80 | 101,944 | |
09/10/2024 | 18.52 | 18.52 | 12.86 | 13.79 | 259,945 | |
09/09/2024 | 13.15 | 19.50 | 12.46 | 19.43 | 488,764 | |
09/06/2024 | 11.70 | 12.57 | 11.35 | 12.51 | 26,972 | |
09/05/2024 | 11.50 | 11.98 | 11.17 | 11.94 | 29,488 |
About Aligos Therapeutics Stock history
Aligos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aligos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aligos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aligos Therapeutics stock prices may prove useful in developing a viable investing in Aligos Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 24.9 M | 33.9 M | |
Net Loss | -86.4 M | -90.8 M |
Aligos Therapeutics Quarterly Net Working Capital |
|
Aligos Therapeutics Stock Technical Analysis
Aligos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Aligos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aligos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aligos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aligos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1058 | |||
Jensen Alpha | 1.29 | |||
Total Risk Alpha | (0.30) | |||
Sortino Ratio | 0.1459 | |||
Treynor Ratio | 1.08 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Aligos Stock Analysis
When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.